Wockhardt Shares Surge 10% After Antibiotic Zaynich Aids in Liver Transplant
Wockhardt’s experimental antibiotic, Zaynich, currently in Phase III clinical trials, played a critical role in facilitating a liver transplant by successfully clearing a chronic bile duct infection in the USA. The company announced this development on December 16, leading to a 10% surge in its share price during early Monday trade. Zaynich eradicated two extreme […]
Wockhardt Shares Surge 10% After Antibiotic Zaynich Aids in Liver Transplant Read More »